by FiveSenses | Jun 28, 2024 | News Release
Vancouver, BC, Canada, June 28th, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to... 
by FiveSenses | Jun 25, 2024 | News Release
Vancouver, BC, Canada, June 25th, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that its second-generation... 
by FiveSenses | Jun 10, 2024 | News Release
Vancouver, BC, Canada, June 10th, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to... 
by FiveSenses | Jun 6, 2024 | News Release
Vancouver, BC, Canada, June 6th, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to...
Recent Comments